Erbitux and Tagamet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erbitux (cetuximab) and Tagamet (cimetidine). Common drug interactions include diarrhoea among females and dermatitis acneiform among males.

The phase IV clinical study analyzes what interactions people have when they take Erbitux and Tagamet. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Erbitux?

Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 19,276 Erbitux users. Check the latest studies of Erbitux.

What is Tagamet?

Tagamet has active ingredients of cimetidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,011 Tagamet users. Check the latest studies of Tagamet.

On Jul, 12, 2026

56 people who take Erbitux and Tagamet together, and have interactions are studied.

What are the common drug interactions of Erbitux and Tagamet, by gender? *:

female:

Diarrhoea
Dizziness
Weight decreased
Hirsutism (abnormal growth of hair on a person's face and body, esp. on a woman)
Abdominal pain lower
Anaemia (lack of blood)
Anaphylactic reaction (serious allergic reaction)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Bone pain

male:

Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Flushing (the warm, red condition of human skin)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Pruritus (severe itching of the skin)
White blood cell count decreased
Back pain
Blood pressure decreased
Chest pain
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Erbitux and Tagamet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Infusion related reaction

40-49:

Infusion related reaction

50-59:

Blood pressure decreased
Erythema (redness of the skin)
Flushing (the warm, red condition of human skin)
Hirsutism (abnormal growth of hair on a person's face and body, esp. on a woman)
Hypotension (abnormally low blood pressure)
Mucosal inflammation (infection of mucous membrane)
Urticaria (rash of round, red welts on the skin that itch intensely)
Anaphylactic reaction (serious allergic reaction)
Back pain
Cardiac failure congestive

60+:

Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Fatigue (feeling of tiredness)
Erythema (redness of the skin)
Headache (pain in head)
Insomnia (sleeplessness)
Pain
Rash
Sinusitis (inflammation of sinus)
Chest discomfort
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Colon Cancer: 19 people, 33.93%
Oral Cancer (mouth cancer): 7 people, 12.50%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 6 people, 10.71%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 7.14%
Pain: 3 people, 5.36%
High Blood Pressure: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Erbitux and Tagamet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously